ANZCTR search results

Primary purpose is to assess the effect of the hospital based walk-in clinic on hospital Emergency Department workload

The purpose of this study is to evaluate the safety and potential effectiveness of CCX140-B in subjects with type 2 diabetes mellitus.

The purpose of this research study is to compare the rate of healing and your perception of pain associated with the treatment of your skin graft donor site. The donor site is the wound left behind when a skin graft has been taken. It is frequently a very uncomfortable wound which usually heals by itself in 10-14 days. Two different types of dressing are being studied. One dressing is currently used typically for donor site care in burn patients on the Burns Unit at the Royal Adelaide Hospital (Duoderm®). This dressing is approved by the Therapeutic Goods Administration for sale and use in Australia. AWBAT-D™ is approved by the Federal Drugs Administration for use and sale in the United States, but in Australia can only be used currently as part of a clinical trial (like this one). The decision regarding which dressing you will receive will be 'random'. If you require two separate donor sites, both materials will be used (one on each site.

Aim: To conduct a prospective trial in a cohort of elderly people to discover the prevalence of dehydration and any association with Omega 3 fatty acid deficiency. This will be followed by a pilot clinical trial aiming to test if 3 month nutritional supplementation with Omega 3 fatty acid may improve thirst sensation, voluntary fluid intake and improve quality of life in comparison with elderly on placebo control. Hypothesis We hypothesise that, there is a positive correlation between prevalence of dehydration and omega 3 fatty acid deficiency in the elderly and supplementation with omega 3 fatty acid will reduce the occurrence of dehydration and improve Quality of life Factors that predispose elderly to dehydration 1. Changes to kidney function and insufficient sensation of thirst. 2. Hormonal changes; normal /increased production of vasopressin, increased response to osmotic stimulation and decreased nocturnal secretions. Atrial natriuretic peptide (ANP) increases secretions with increased stimulation, decreased renin activity and aldosterone production. 3. Neurological impairments altering the hypothalamus and pituitary gland, which affect sensation of thirst. 4. Medication (for example, diuretics and laxatives). 5. Chronic illness, communication issues cognitive difficulties and limited mobility. 6. Not drinking enough water to avoid occurrence of incontinence. 7. Fuid loss due to diarrhoea or vomiting and not compensating for loss. Outcome Improved thirst sensation, voluntary fluid intake and improve quality of life in elderly subjects.

The LoDoCo VRIC study aims to investigate the effect of low dose colchicine on inflammatory markers and coronary artery disease as measured by a surrogate marker, brachial artery flow mediated dilation in a stable coronary artery disease population.

The standard clinical advice for individuals who suffer from recurrent headaches is that ‘the best way to prevent headaches is to avoid the triggers’. There is a plausible argument that such advice may be counter to the interests of headache suffers as it could lead to increased sensitisation and decreased tolerance of headache triggers and therefore more headaches. Research results suggest that it should be possible to increase individual’s tolerance of headache triggers through prolonged exposure for desensitisation or providing exposure as an opportunity to practice coping with headache triggers. The proposed study seeks to compare a psychological treatment that advocates avoidance of headache triggers, with a coping approach that uses exposure to triggers (supported by relaxation and cognitive techniques) except where this is not possible or would seem inappropriate. It is predicted that exposure will increase tolerance to headache triggers and lead to fewer headaches in the long term, whereas avoidance may at best provide short term relief. The study results will have important implications for our understanding of how headache disorders can be more effectively managed in the future.

The REVITAHIP trial is a multicentre randomized-controlled trial examining the effects of early high-dose vitamin D replacement compared to placebo in improving mobility and reducing disability in older people following a hip fracture

Recent research indicates that shoe inserts are effective in treating some individuals with knee pain. However, not all individuals benefit from shoe inserts and research to determine who is most likely to benefit is limited. Therefore, this study is aiming to identify predictors of individuals with knee pain most likely to benefit from shoe inserts.

This pilot study aims to gain preliminary information on the utility of C-MET and FLT PET-CT imaging for distinguishing ‘pseudoprogression’ from ‘true’ progression in patients receiving chemoradiotherapy for high grade glioma. C-MET and FLT PET-CT scans will be performed at the same time as their routine mid-treatment MRI (after 2-3 cycles of chemotherapy. Patients will be followed to record radiological and clinical responses to chemotherapy. Patients will also be followed up for survival. This data will be used to obtain preliminary information of the prognostic significance of C-MET and FLT PET-CT imaging in glioma

Food allergies are common and result in a significant burden to families and the health care system. One approach to prevent food allergies may be to introduce specific foods earlier than currently recommended. The study will compare early regular introduction of egg from 4-6.5 months of age compared to the more common practice of egg avoidance until 10 months of age. If successful at reducing egg allergy, this approach will have a significant impact on reducing the burden of allergic disease.